On 4 December 2020, LifeTech Scientific Corporation entered into a placement agreement with the Citigroup Global Markets Limited. The Company will place 287,320,000 new shares at the price of HK$3.2368 per placing share.
On 24 November 2020, Biotyx Medical (Shenzhen) Co., Ltd. , a holding subsidiary of Lifetech Scientific，specialized in research, development, manufacture and sales of metal-based bioresorbable medical devices, has successfully introduced series A strategic investors, including IDG Capital and Co-Stone Asset Management.
On 24 November 2020, LifeTech Scientific Corporation noticed that Central Huijin Investment Ltd. has transacted its entire equity interests in the Company to Hillhouse Capital and GL Capital.
LifeTech Scientific Corporation (the “Company”) and its subsidiaries (the “Group”) announced the unaudited consolidated results for the six months ended 30 June 2020 (the “Reporting Period”)
30th March, 2020,LifeTech Scientific Corporation (the “Company”) and its subsidiaries (the “Group”) announced the audited consolidated results for the year ended 31 December 2019 (the “Reporting Period”)
LifeTech Scientific Corporation announced that it had entered into the Agreement with the wholly-owned subsidiary of China Everbright Limited, agreed to purchase, with funding to be provided by the Company, and the Vendor conditionally agreed to sell, an aggregate of not more than 300,000,000 shares, for the purpose of the Share Award Scheme.
On the afternoon of December 20, 2018, Jia Xingdong, Director of Shenzhen Municipal Commission of Economic Trade and Information Technology, and his delegation visited Lifetech for investigation
In 2018, Lifetech was approved to obtain two key national R&D program projects.
On December 5, 2018, Lifetech (1302.HK) was granted the 8th China Securities "Golden Bauhinia" Award for "Best Investor Relations Management Listed Companies". This award was obtained by Lifetech in three consecutive years.
Recently, sixteen members of the Thai-Chinese Culture & Economic Association and the Thai government and business delegation visited Lifetech. Mr. Xie Yuehui, Chairman and CEO of Lifetech was present at the reception ceremony.